Zhong Yuan Bio-Technology Holdings Limited
ZHYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 6.61% | 19.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 6.61% | 19.88% |
| Cost of Revenue | -- | -- | -- | 93.36% | 45.12% |
| Gross Profit | -- | -- | -- | -55.63% | -32.99% |
| SG&A Expenses | -- | -- | -- | -21.55% | -12.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 64.04% | 67.83% |
| Operating Income | -- | -- | -- | -950.08% | -1,297.54% |
| Income Before Tax | -- | -- | -- | -3,598.90% | -2,042.55% |
| Income Tax Expenses | -- | -- | -- | -312.50% | -200.00% |
| Earnings from Continuing Operations | -- | -- | -- | -3,211.63% | -1,911.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -3,945.54% | -2,824.56% |
| EBIT | -- | -- | -- | -950.08% | -1,297.54% |
| EBITDA | -- | -- | -- | -1,000.51% | -1,427.07% |
| EPS Basic | -- | -- | -- | -3,787.50% | -2,775.00% |
| Normalized Basic EPS | -- | -- | -- | -2,983.33% | -2,118.18% |
| EPS Diluted | -- | -- | -- | -3,787.50% | -2,775.00% |
| Normalized Diluted EPS | -- | -- | -- | -2,983.33% | -2,118.18% |
| Average Basic Shares Outstanding | -- | -- | -- | 1.78% | 1.04% |
| Average Diluted Shares Outstanding | -- | -- | -- | 1.78% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |